79 related articles for article (PubMed ID: 21242521)
41. Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC.
Wu CL; Caumartin J; Amodio G; Anna F; Loustau M; Gregori S; Langlade-Demoyen P; LeMaoult J
Front Immunol; 2020; 11():608614. PubMed ID: 33505397
[TBL] [Abstract][Full Text] [Related]
42. Roles of HLA-G in the Maternal-Fetal Immune Microenvironment.
Xu X; Zhou Y; Wei H
Front Immunol; 2020; 11():592010. PubMed ID: 33193435
[TBL] [Abstract][Full Text] [Related]
43. The Challenge of Distinguishing Cell-Cell Complexes from Singlet Cells in Non-Imaging Flow Cytometry and Single-Cell Sorting.
Burel JG; Pomaznoy M; Lindestam Arlehamn CS; Seumois G; Vijayanand P; Sette A; Peters B
Cytometry A; 2020 Nov; 97(11):1127-1135. PubMed ID: 32400942
[TBL] [Abstract][Full Text] [Related]
44. Extracellular vesicles in allograft rejection and tolerance.
Benichou G; Wang M; Ahrens K; Madsen JC
Cell Immunol; 2020 Mar; 349():104063. PubMed ID: 32087929
[TBL] [Abstract][Full Text] [Related]
45. Circulating T cell-monocyte complexes are markers of immune perturbations.
Burel JG; Pomaznoy M; Lindestam Arlehamn CS; Weiskopf D; da Silva Antunes R; Jung Y; Babor M; Schulten V; Seumois G; Greenbaum JA; Premawansa S; Premawansa G; Wijewickrama A; Vidanagama D; Gunasena B; Tippalagama R; deSilva AD; Gilman RH; Saito M; Taplitz R; Ley K; Vijayanand P; Sette A; Peters B
Elife; 2019 Jun; 8():. PubMed ID: 31237234
[TBL] [Abstract][Full Text] [Related]
46. Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8
Desgrandchamps F; LeMaoult J; Goujon A; Riviere A; Rivero-Juarez A; Djouadou M; de Gouvello A; Dumont C; Wu CL; Culine S; Verine J; Rouas-Freiss N; Hennequin C; Masson-Lecomte A; Carosella ED
Oncotarget; 2018 Sep; 9(69):33160-33169. PubMed ID: 30237859
[TBL] [Abstract][Full Text] [Related]
47. Maintaining T cell tolerance of alloantigens: Lessons from animal studies.
Robinson KA; Orent W; Madsen JC; Benichou G
Am J Transplant; 2018 Aug; 18(8):1843-1856. PubMed ID: 29939471
[TBL] [Abstract][Full Text] [Related]
48. Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond.
Ralston KS
Curr Opin Microbiol; 2015 Dec; 28():26-35. PubMed ID: 26277085
[TBL] [Abstract][Full Text] [Related]
49. Trogocytic intercellular membrane exchanges among hematological tumors.
LeMaoult J; Caumartin J; Daouya M; Switala M; Rebmann V; Arnulf B; Carosella ED
J Hematol Oncol; 2015 Mar; 8():24. PubMed ID: 25887663
[TBL] [Abstract][Full Text] [Related]
50. The dual role of HLA-G in cancer.
Rouas-Freiss N; Moreau P; LeMaoult J; Carosella ED
J Immunol Res; 2014; 2014():359748. PubMed ID: 24800261
[TBL] [Abstract][Full Text] [Related]
51. HLA-dependent tumour development: a role for tumour associate macrophages?
Marchesi M; Andersson E; Villabona L; Seliger B; Lundqvist A; Kiessling R; Masucci GV
J Transl Med; 2013 Oct; 11():247. PubMed ID: 24093459
[TBL] [Abstract][Full Text] [Related]
52. Th cells promote CTL survival and memory via acquired pMHC-I and endogenous IL-2 and CD40L signaling and by modulating apoptosis-controlling pathways.
Umeshappa CS; Xie Y; Xu S; Nanjundappa RH; Freywald A; Deng Y; Ma H; Xiang J
PLoS One; 2013; 8(6):e64787. PubMed ID: 23785406
[TBL] [Abstract][Full Text] [Related]
53. Trogocytosis results in sustained intracellular signaling in CD4(+) T cells.
Osborne DG; Wetzel SA
J Immunol; 2012 Nov; 189(10):4728-39. PubMed ID: 23066151
[TBL] [Abstract][Full Text] [Related]
54. Engineering lymph node homing of ex vivo-expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7.
Somanchi SS; Somanchi A; Cooper LJ; Lee DA
Blood; 2012 May; 119(22):5164-72. PubMed ID: 22498742
[TBL] [Abstract][Full Text] [Related]
55. Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity.
HoWangYin KY; Caumartin J; Favier B; Daouya M; Yaghi L; Carosella ED; LeMaoult J
J Immunol; 2011 Feb; 186(4):2210-8. PubMed ID: 21242521
[TBL] [Abstract][Full Text] [Related]
56. Ligand binding but undetected functional response of FcR after their capture by T cells via trogocytosis.
Hudrisier D; Clemenceau B; Balor S; Daubeuf S; Magdeleine E; Daëron M; Bruhns P; Vié H
J Immunol; 2009 Nov; 183(10):6102-13. PubMed ID: 19841164
[TBL] [Abstract][Full Text] [Related]
57. Membrane redistributions through multi-intercellular exchanges and serial trogocytosis.
Alegre E; Howangyin KY; Favier B; Baudhuin J; Lesport E; Daouya M; Gonzalez A; Carosella ED; Lemaoult J
Cell Res; 2010 Nov; 20(11):1239-51. PubMed ID: 20877312
[TBL] [Abstract][Full Text] [Related]
58. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
Gumá M; Busch LK; Salazar-Fontana LI; Bellosillo B; Morte C; García P; López-Botet M
Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
[TBL] [Abstract][Full Text] [Related]
59. Visualizing how T cells collect activation signals in vivo.
Moreau HD; Bousso P
Curr Opin Immunol; 2014 Feb; 26():56-62. PubMed ID: 24556401
[TBL] [Abstract][Full Text] [Related]
60. Lymphocytes and Trogocytosis-Mediated Signaling.
Reed J; Reichelt M; Wetzel SA
Cells; 2021 Jun; 10(6):. PubMed ID: 34204661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
